Home

AML

 

HARMONY Alliance Foundation at ELN Symposyum
ASH 2024: HARMONY Alliance activities at the 66th Annual Meeting of the American Society of Hematology
HARMONY Alliance present at the Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology
Scientific abstract presentations at EHA2024
Presenting about HARMONY MDS and AML research at EBMT2024
New research on patient outcomes presented at the 65th Annual Meeting of the American Society of Hematology
HARMONY Acute Promyelocytic Leukemia (APL) abstract presented at EHA2023
AML-7: The impact of gender on genetic aberrations and clinical outcomes in AML
AML-8: Clinical Meaning and Prognostic Implications of Non-Canonical Non-Type A NPM1 Mutations in Acute Myeloid Leukemia
AML-6: Unravelling the Clinical Impact of Co-mutations in NPM1mut AML
PRESS RELEASE: HARMONY presents new insights in prognosis of AML patients
IHI publishes about HARMONY AML Research Result
PRESS RELEASE: New AML and CLL research results from HARMONY to facilitate tailored treatment choices in subtypes of blood cancer
#Bigdataforbloodcancer Blog: Selecting the right treatment for the right patient: The HARMONY approach.
AML-5: Exploring a role for HARMONY data as historical control in elderly Acute Myeloid Leukemia patients.
AML-4: Using big data to confirm the link between MRD and survival in AML
AML-3: Using big data to shed light on the clinical impact of genomic alterations in sAML/tAML
AML: Delphi Survey: Towards a Core Outcome Set for Acute Myeloid Leukemia
AML-2: Optimizing Acute Promyelocytic Leukemia Management Using Big Data
AML-1: Use of Big Data to revise treatment strategies in Acute Myeloid Leukemia